Navigation Links
Genaera Corporation Presents Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at Keystone Symposia
Date:1/24/2008

iabetes now in effect and the positive metabolic data from our first completed Phase 1 study in obesity, we are executing upon our strategy to evaluate the potential of MSI-1436 to impact both type 2 diabetes and obesity."

The poster entitled "Trodusquemine (MSI-1436) Enhances Glucose Tolerance in a Murine Model of Insulin Resistance" will be displayed from 7:30 p.m. to 10:00 p.m. MT at the Beaver Run Resort in Breckenridge, Colorado.

About Trodusquemine (MSI-1436)

Trodusquemine is a centrally and peripherally-acting appetite suppressant and the first highly selective inhibitor of protein tyrosine phosphatase 1B (PTP-1B). PTP-1B is central to controlling the function of both the leptin and insulin pathways. By inhibiting PTP-1B, MSI-1436 is expected to decrease appetite and normalize blood sugar. Trodusquemine has produced consistent, sustainable weight loss in a variety of animal models and appears to overcome metabolic readjustment, which often limits sustained weight loss during caloric restriction. In addition, trodusquemine has shown the ability to reverse co-morbidities associated with obesity such as abnormal glucose metabolism and cholesterol elevation.

About Genaera

Genaera Corporation is focused on advancing the science and treatment of metabolic diseases. The Company has significant market opportunities with a first-in-class molecule, trodusquemine (MSI-1436), that has the potential to redefine the treatment paradigm for obesity and type 2 diabetes and is presently in a Phase 1 trial in obesity. In addition, Genaera has a value- driven, fully out-licensed partnership with MedImmune, Inc. for a second core program that is presently undergoing Phase 2 clinical testing in asthma. Genaera is committed to directing resources to its core program and the aggressive clinical development of its key assets to build stockholder value. For further information, please see our website at
'/>"/>

SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
3. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
4. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
5. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
6. Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436)
7. Genaera Announces Diabetes IND In Effect for Trodusquemine (MSI-1436)
8. CEL-SCI Corporation Releases Letter to Shareholders
9. Alfacell Corporation to Present at UBS Global Life Sciences Conference
10. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
11. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (the "Company") (NASDAQ: CLSN ) today announced ... purchase an aggregate of approximately $15 million of the ... led by a dedicated health care fund. ... investors pursuant to which the Company agreed to sell ...
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness ... Fitness Center by the Medical Fitness Association, a non-profit ... achieve their full potential. The Cadence Fitness & Health ... western suburbs and second in the Chicagoland area. ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
(Date:4/18/2014)... Ky. (April 21, 2014) -- A group of ... Medicine and the Sanders-Brown Center on Aging has ... depression and neuropsychological function in Parkinson,s disease (PD). ... Research , the study, which assessed cognitive function ... that the dopamine replacement therapy commonly used to ...
(Date:4/18/2014)... memories? How did it make you feel? According to ... experience, such as how sad you were or how ... when you can,t stop thinking about it. , ... context of the memories, rather than how you felt, ... the negative effects of these memories, a new study ...
(Date:4/18/2014)... Medicine scientists could lead to potential new treatments for ... scleroderma. , Fibrosis, or scarring, is a hallmark ... and lungs can lead to serious organ damage and, ... therapeutic options centers on findings made by Swati Bhattacharyya, ... role that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... most popular vaccine brands for children may not be ... some cost factors when choosing vaccines, driving the market ... to a new study by University of Illinois researchers. ... driven by numerous factors," says Sheldon H. Jacobson, a ... science and of mathematics at the U. of I. ...
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
Breaking Medicine News(10 mins):Health News:Treating depression in PD patients: New research 2Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:New clues on tissue scarring in scleroderma 2Health News:Study recalculates costs of combination vaccines 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2
... by Virginia Kaklamani, MD, an oncologist at Northwestern Memorial ... School of Medicine, variations of the adiponectin gene, which ... womans risk of developing breast cancer. This discovery is ... it could help experts develop a future genetic testing ...
... NEW YORK (April 25, 2008) -- Heart failure patients ... first to be implanted with the HeartMate II LVAS ... that helps weak hearts pump blood -- that has ... 21 for broad use as bridge to transplantation. As ...
... County Sees Sharp Rise in Gonorrhea Cases, HARRISBURG, Pa., ... of cases of Gonorrhea last year in Delaware County,the Pennsylvania ... of 15 and 24 be routinely screened for the,disease, as ... Gonorrhea grew to 921 in 2007 from 513,the year before., ...
... With an aggressive growth plan in,effect for 2008, YoNaturals ... big step in their expansion efforts with new,vending locations ... of 2006, YoNaturals has maintained a strong,dedication toward changing ... have experienced thus far is in large part due ...
... Winner Renee Zellweger ("Chicago") Reteams with Craig Zadan and Neil Meron, Executive ... Producers for the Sony Pictures Television Project, Based ... a Doctor,s Dramatic Quest to Develop the Lifesaving Breast Cancer ... Drug Herceptin ...
... The Lupus Foundation of,America joins a coalition of approximately ... on May 10. More than 1.5 million,Americans and at ... they struggle daily with the often-debilitating health,consequences of the ... of an unbalanced immune system that can become,destructive to ...
Cached Medicine News:Health News:Study shows gene variations may predict risk of breast cancer in women 2Health News:FDA approves HeartMate II mechanical heart pump for heart-failure patients 2Health News:Gulfport-Biloxi Airport Welcomes Installation of New YoNaturals Healthy Vending Machines 2Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 2Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 3Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 4Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 5Health News:Lupus Organizations Issue International Call-to-Action to Combat Disease Affecting Five Million People 2
Three-spring evacuator kits with silicone drains, 10 in. hole pattern, trocar and Y-connector tubing...
Provides reliable suction for surgical cases with larger amounts of drainage....
Offers a more constant suction profile than three-spring evacuators, resulting in the potential for improved tissue approximation and reduced risk of hematoma....
Reliavac® 400cc kits with siliconized PVC drain, Y-connector tube...
Medicine Products: